Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Sat Dec 16 14:27:11 GMT 2023
by
admin
on
Sat Dec 16 14:27:11 GMT 2023
|
| Source Materials Class | ORGANISM |
| Source Materials Type | ALLOGENIC HUMAN |
| Source Materials State | LIVE |
| Source Materials Parent | |
| Part | BLOOD |
| Fraction Material Type | CELLS |
| Fraction Name | HLA-typed EBV seropositive OR primary stem cell donor T cells |
| Record UNII |
G3NJ7M8N4H
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
487015
Created by
admin on Sat Dec 16 14:27:11 GMT 2023 , Edited by admin on Sat Dec 16 14:27:11 GMT 2023
|
||
|
NCI_THESAURUS |
C28681
Created by
admin on Sat Dec 16 14:27:11 GMT 2023 , Edited by admin on Sat Dec 16 14:27:11 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/16/1627
Created by
admin on Sat Dec 16 14:27:11 GMT 2023 , Edited by admin on Sat Dec 16 14:27:11 GMT 2023
|
||
|
NCI_THESAURUS |
C129826
Created by
admin on Sat Dec 16 14:27:11 GMT 2023 , Edited by admin on Sat Dec 16 14:27:11 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
G3NJ7M8N4H
Created by
admin on Sat Dec 16 14:27:11 GMT 2023 , Edited by admin on Sat Dec 16 14:27:11 GMT 2023
|
PRIMARY | |||
|
C143140
Created by
admin on Sat Dec 16 14:27:11 GMT 2023 , Edited by admin on Sat Dec 16 14:27:11 GMT 2023
|
PRIMARY | |||
|
DE-131
Created by
admin on Sat Dec 16 14:27:11 GMT 2023 , Edited by admin on Sat Dec 16 14:27:11 GMT 2023
|
PRIMARY | |||
|
10640
Created by
admin on Sat Dec 16 14:27:11 GMT 2023 , Edited by admin on Sat Dec 16 14:27:11 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->CYTOTOXIC T-CELL |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| CULTURED | T-CELL STIMULATION | IMMUNOLOGICAL |
|
UNSPECIFIED SUBSTANCE | 35e8aec3 |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| HLA TYPED | BIOLOGICAL |
|